Clinical Trial: A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Breast Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Brief Summary:
This is a Phase 1 dose-escalation study of PRT3645, a Cyclin-dependent Kinase 4/6 (CDK4/6) inhibitor, in patients with advanced or metastatic solid tumors.The purpose of this study is to investigate the safety, tolerability, dose limiting toxicity, and to determine maximally tolerated dose and recommended phase 2 dose to be used in subsequent development of PRT3645.
Read more